Voyager Therapeutics (VYGR) Other Non-Current Assets: 2015-2025
Historic Other Non-Current Assets for Voyager Therapeutics (VYGR) over the last 10 years, with Sep 2025 value amounting to $5.6 million.
- Voyager Therapeutics' Other Non-Current Assets rose 95.34% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 95.34%. This contributed to the annual value of $2.9 million for FY2024, which is 80.41% up from last year.
- Latest data reveals that Voyager Therapeutics reported Other Non-Current Assets of $5.6 million as of Q3 2025, which was up 95.34% from $2.9 million recorded in Q2 2025.
- In the past 5 years, Voyager Therapeutics' Other Non-Current Assets registered a high of $5.6 million during Q3 2025, and its lowest value of $1.5 million during Q2 2022.
- In the last 3 years, Voyager Therapeutics' Other Non-Current Assets had a median value of $2.9 million in 2025 and averaged $2.7 million.
- As far as peak fluctuations go, Voyager Therapeutics' Other Non-Current Assets slumped by 32.58% in 2022, and later surged by 95.34% in 2025.
- Quarterly analysis of 5 years shows Voyager Therapeutics' Other Non-Current Assets stood at $1.8 million in 2021, then fell by 14.84% to $1.5 million in 2022, then grew by 5.15% to $1.6 million in 2023, then skyrocketed by 80.41% to $2.9 million in 2024, then surged by 95.34% to $5.6 million in 2025.
- Its last three reported values are $5.6 million in Q3 2025, $2.9 million for Q2 2025, and $2.9 million during Q1 2025.